ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE rejects rare eye disease drug
pharmatimes
March 21, 2018Cost regulators for NHS therapies in England and Wales have published draft guidelines rejecting funding for Dompé’s cenegermin as a treatment for neurotrophic keratitis, a rare eye condition.
Pharma Sources Insight January 2025
